W Bi

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

Emmanuel Beillard, Niels Pallisgaard, Vincent H. J. van der Velden et al. · Leukemia · 2003 · 879 citations

Hematological Malignancy, Polymerase Chain Reaction, Prognostic Biomarkers +11

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay

Guido Marcucci, KJ Livak, W Bi et al. · Leukemia · 1998 · 162 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Pre-Clinical Validation of a Novel, Highly Sensitive Assay to Detect PML-RARα mRNA Using Real-Time Reverse-Transcription Polymerase Chain Reaction

James L. Slack, W Bi, Kenneth J. Livak et al. · Journal of Molecular Diagnostics · 2001 · 52 citations · Full text

Engineering, Pml-rarα Mrna, Highly Sensitive Assay +9

HSV-tk Gene Therapy in Head and Neck Squamous Cell Carcinoma: Enhancement by the Local and Distant Bystander Effect

Keith Wilson, P J Stambrook, W Bi et al. · Archives of Otolaryngology - Head and Neck Surgery · 1996 · 38 citations

Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure

Robert E. Gallagher, Esther Schachter-Tokarz, D-C Zhou et al. · Leukemia · 2006 · 27 citations · Full text

Hematological Malignancy, Pml-rarα Mutant Subclones, Medicine +10